Prosthetic Valves And Related Inventions
US-2020038179-A1 · Feb 6, 2020 · US
US10799356B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-10799356-B2 |
| Application number | US-201816116307-A |
| Country | US |
| Kind code | B2 |
| Filing date | Aug 29, 2018 |
| Priority date | Sep 12, 2017 |
| Publication date | Oct 13, 2020 |
| Grant date | Oct 13, 2020 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
A mitral regurgitation treatment system may include an annuloplasty device configured for placement on an atrial side of a mitral valve, a tethering element configured to extend between a first papillary muscle and a second papillary muscle, wherein the tethering element includes a first anchor securing the tethering element to the first papillary muscle and a second anchor securing the tethering element to the second papillary muscle, and a linking element extending from the annuloplasty device to the tethering element. The linking element may include a spring element disposed between the annuloplasty device and the tethering element.
Opening claim text (preview).
What is claimed is: 1. A mitral regurgitation treatment system, comprising: an annuloplasty device configured for placement on an atrial side of a mitral valve; a tethering element configured to extend between a first papillary muscle and a second papillary muscle, wherein the tethering element includes a first anchor securing the tethering element to the first papillary muscle and a second anchor securing the tethering element to the second papillary muscle; and a linking element extending from the annuloplasty device to the tethering element; wherein the linking element includes a spring element disposed between the annuloplasty device and the tethering element; wherein the first anchor includes a first anchoring element configured to be positioned against an outer surface of the first papillary muscle and a second anchoring element configured to be positioned against the outer surface of the first papillary muscle opposite the first anchoring element such that the first papillary muscle is disposed between the first anchoring element and the second anchoring element and a first portion of the tethering element passes through the first papillary muscle; wherein the second anchor includes a third anchoring element configured to be positioned against an outer surface of the second papillary muscle and a fourth anchoring element configured to be positioned against the outer surface of the second papillary muscle opposite the third anchoring element such that the second papillary muscle is disposed between the third anchoring element and the fourth anchoring element and a second portion of the tethering element passes through the second papillary muscle. 2. The mitral regurgitation treatment system of claim 1 , wherein the linking element connects to the tethering element along a length of the tethering element. 3. The mitral regurgitation treatment system of claim 1 , wherein the linking element is configured to connect to the tethering element at a location between the first papillary muscle and the second papillary muscle. 4. The mitral regurgitation treatment system of claim 1 , wherein the spring element maintains the linking element in tension between the annuloplasty device and the tethering element. 5. The mitral regurgitation treatment system of claim 4 , further comprising a crimping element disposed on the linking element and configured to engage an outer surface of the annuloplasty device. 6. The mitral regurgitation treatment system of claim 1 , wherein the linking element extends through the annuloplasty device. 7. The mitral regurgitation treatment system of claim 6 , wherein the linking element extends through the annuloplasty device in a direction generally parallel to fluid flow through the mitral valve. 8. The mitral regurgitation treatment system of claim 1 , wherein the linking element is configured to extend through tissue of the mitral valve. 9. The mitral regurgitation treatment system of claim 1 , wherein the spring element is formed from nitinol. 10. A mitral regurgitation treatment system, comprising: an annuloplasty device configured for placement on an atrial side of a mitral valve; a tethering element configured to extend between a first papillary muscle and a second papillary muscle, wherein the tethering element includes a first anchor securing the tethering element to the first papillary muscle and a second anchor securing the tethering element to the second papillary muscle; and a linking element extending from the annuloplasty device to the tethering element; wherein the first anchor includes a first anchoring element configured to be positioned against an outer surface of the first papillary muscle and a second anchoring element configured to be positioned against the outer surface of the first papillary muscle opposite the first anchoring element such that the first papillary muscle is disposed between the first anchoring element and the second anchoring element and a first portion of the tethering element passes through the first papillary muscle; wherein the second anchor includes a third anchoring element configured to be positioned against an outer surface of the second papillary muscle and a fourth anchoring element configured to be positioned against the outer surface of the second papillary muscle opposite the third anchoring element such that the second papillary muscle is disposed between the third anchoring element and the fourth anchoring element and a second portion of the tethering element passes through the second papillary muscle. 11. The mitral regurgitation treatment system of claim 10 , wherein the linking element is connected to the tethering element between the first portion and the second portion. 12. The mitral regurgitation treatment system of claim 11 , wherein the linking element is slidable along the tethering element. 13. The mitral regurgitation treatment system of claim 10 , wherein at least one of the tethering element and the linking element comprise a multi-strand suture. 14. The mitral regurgitation treatment system of claim 10 , wherein the tethering element is configured to extend between the first papillary muscle and the second papillary muscle in tension. 15. A method of delivering a mitral regurgitation system, comprising: inserting a delivery catheter percutaneously through a vasculature to a left atrium of a heart; deploying an annuloplasty device from the delivery catheter on an atrial side of a mitral valve of the heart; extending a tethering element through the annuloplasty device and into a left ventricle of the heart; anchoring the tethering element to a first papillary muscle; anchoring the tethering element to a second papillary muscle such that the tethering element is in tension between the first papillary muscle and the second papillary muscle; and securing a linking element extending from the tethering element to the annuloplasty device in tension, the linking element including a spring element disposed between the annuloplasty device and the tethering element. 16. The method of claim 15 , wherein extending the tethering element includes extending an anchor delivery catheter from the delivery catheter through the annuloplasty device and into the left ventricle of the heart. 17. The method of claim 15 , wherein anchoring the tethering element to the first papillary muscle includes passing a first portion of the tethering element through the first papillary muscle. 18. The method of claim 15 , wherein anchoring the tethering element to the second papillary muscle includes passing a second portion of the tethering element through the second papillary muscle. 19. The method of claim 15 , wherein securing the linking element includes feeding a crimping element over the linking element and into engagement with the annuloplasty device.
Annuloplasty rings in direct contact with the valve annulus · CPC title
Chordae tendineae prostheses · CPC title
magnetic · CPC title
cardiac · CPC title
Means for preventing inversion of the valve leaflets, e.g. chordae tendineae prostheses · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.